Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1659 of 5804
-
Immunotherapy before surgery shows promise for oral cancer
Disease control CompletedThe purpose of this study is to look at the effectiveness of nivolumab in patients with oral cavity cancer (OCC) who are about to undergo surgery.
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug shows promise for painful hand and foot psoriasis
Disease control CompletedThe primary objective of this trial is to investigate the safety and efficacy of BI 655130 in patients with PPP following multiple intravenous administrations compared to placebo.
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Immunotherapy combo shows promise for rare salivary cancer
Disease control CompletedThe purpose of this study is to find out what effects, good and/or bad, treatment with two drugs called nivolumab and ipilimumab have on the participant and salivary cancer.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New stem cell transplant approach aims to tame deadly bone marrow cancer
Disease control OngoingThis pilot phase I trial studies the side effects of combination chemotherapy, total body irradiation, and donor blood stem cell transplant in treating patients with secondary myelofibrosis. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, eit…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug metformin tested to boost walking in artery disease patients
Disease control CompletedThe PERMET trial will determine whether metformin daily for six months improves six-minute walk performance in individuals with peripheral artery disease compared to placebo.
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New trial tests shorter radiation for head and neck cancer that has returned
Disease control TerminatedThis phase II trial studies how well stereotactic body radiation therapy or intensity modulated radiation/proton therapy works in treating patients with head and neck cancer that has come back. Stereotactic body radiation therapy uses special equipment to position a patient and d…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Hepatitis c care at opioid clinics boosts treatment access
Disease control CompletedINTRO-HCV is a multicentre randomised controlled clinical trial that will compare the efficacy of integrated treatment of chronic hepatitis C virus infection (HCV) within medically assisted rehabilitation (MAR) clinics providing opioid substitution therapy (OST) compared to stand…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
New combo aims to outsmart prostate cancer without Long-Term hormone shots
Disease control CompletedThis is a non-comparative open-label multicenter Phase 2 clinical trial combining stereotactic body radiation therapy (SBRT) and pembrolizumab with or without intratumoral SD-101 in participants with newly diagnosed hormone-naive oligometastatic prostate cancer.
Phase: PHASE2 • Sponsor: David Oh • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for bladder cancer patients who can't take chemo
Disease control OngoingThis study evaluates the post cystectomy CD8+ tumor response of patients receiving Nivolumab plus Urelumab versus Nivolumab alone. Half the patients will receive Nivolumab plus Urelumab, while the other half will receive Nivolumab alone.
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Poop pills may tame deadly transplant complication
Disease control Recruiting nowWith the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immunotherapy duo takes on resistant germ cell tumors
Disease control OngoingThe purpose of this study is to test the safety and effectiveness of durvalumab with tremelimumab in patients with relapsed or refractory germ cell tumors.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Lung cancer trial targets tumor diversity to outsmart resistance
Knowledge-focused CompletedDARWIN II is a multi-arm non-randomised phase II trial, Eligible patient will be those who relapse with NSCLC (clinical trials.gov ref. NCT02183883). . The trial will investigate assess if intra-tumour heterogeneity (clonal vs subclonal actionable mutation) is associated with PF…
Phase: PHASE2 • Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New stroke registry aims to unlock secrets of brain damage
Knowledge-focused Recruiting nowThis is a prospective open enrollment biorepository to collect and evaluate blood and tissue collected during cerebrovascular procedures, which will then be used for the purposes of identifying biological markers, inflammatory cell infiltrates, and biological states in stroke and…
Sponsor: Justin Fraser • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New study tests best TAVI valve for small heart valves
Disease control OngoingThe treatment with transcatheter aortic valve implantation (TAVI) of patients with small (≤23mm) surgical bioprostheses remains a challenge due to the increased transvalvular residual gradients and high rates of severe prosthesis-patient mismatch (PPM) following the procedure.
Phase: NA • Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New MRI technique could replace biopsy for brain tumor grading
Diagnosis OngoingBrain tumors, despite their relatively low incidence among cancers, are associated with high morbidity and mortality due to the brain's complexity. Biopsy, the gold standard for tumor grading, is limited by invasiveness, costs, and sampling issues. Conventional MR imaging lacks s…
Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New hip implant coating aims to cut infection risk and boost bone bonding
Disease control OngoingThe infection rate after Total Hip Arthroplasty (THA) is about 1%. It is a serious condition, with high morbidity, sometimes fatal, requiring costly treatment. The treatment is difficult because "biofilm" forms very early after the bacterial contamination of the prosthesis. Pre…
Phase: NA • Sponsor: Societe ACTIVBIOMAT • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Engineered t cells take on lymphoma in early trial
Disease control Recruiting nowThe subject has a type of lymph gland cancer called Lymphoma. The body has different ways of fighting infection and disease. No single way seems perfect for fighting cancer. This research study combines two different ways of fighting disease: antibodies and T cells. T cells, als…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common Parkinson's drug help treat wet AMD?
Disease control CompletedFrom 3 large patient databases, patients diagnosed with AMD who have never taken levodopa(L-DOPA) containing medications have a mean age of diagnosis at 71 years. Patients who have been treated with L-DOPA containing medications have a mean age of diagnosis of AMD at 79 years. L…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated Jun 26, 2026 16:03 UTC
-
Heart surgery breathing study aims to cut lung failure risk
Disease control CompletedBACKGROUND. Postoperative pulmonary complications are a leading cause of morbidity and mortality after cardiac surgery. To this date, there are no recommendations regarding mechanical ventilation associated with cardiopulmonary bypass (CPB) during the surgery and anesthesiologist…
Phase: NA • Sponsor: CMC Ambroise Paré • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a common Parkinson's pill help treat wet AMD?
Disease control CompletedFrom 3 large patient databases, patients diagnosed with AMD who have never taken levodopa(L-DOPA) containing medications have a mean age of diagnosis at 71 years. Patients who have been treated with L-DOPA containing medications have a mean age of diagnosis of AMD at 79 years. L…
Phase: PHASE2 • Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. • Aim: Disease control
Last updated Jun 26, 2026 16:39 UTC